Home Newsfeeds Stephens & Co. Reiterates Overweight on Stoneridge, Maintains $27 Price Target

Stephens & Co. Reiterates Overweight on Stoneridge, Maintains $27 Price Target

Stephens & Co. analyst Justin Long reiterates Stoneridge (NYSE:SRI) with a Overweight and maintains $27 price target.

byBenzinga Newsdesk

March 2, 2023

1 minute read

Stephens & Co. analyst Justin Long reiterates Stoneridge (NYSE:SRI) with a Overweight and maintains $27 price target.

Telsey Advisory Group Maintains Outperform on Deckers Outdoor, Raises Price Target to $475

By Benzinga Newsdesk

January 26, 6:31 AM

Telsey Advisory Group analyst Dana Telsey maintains Deckers Outdoor (NYSE:DECK) with a Outperform and raises the price target from $410 to $475.

DECK

What’s Going On With 4D Molecular Therapeutics Stock Today

By Vandana Singh

April 27, 2:29 PM

4D Molecular Therapeutics (NASDAQ: FDMT) shares are trading lower after the company released interim clinical data from the Phase 1 Dose Exploration stage of the 4D-150 Phase 1/2 PRISM trial for wet age-related

FDMT

Wind Of Change: Energy Giants Equinor & BP Give Offshore Wind Power Project Deal A Second Chance

By Lekha Gupta

January 26, 8:21 AM

In a cash-neutral move, Equinor and BP redefine offshore wind territories. While Equinor eyes NY's offshore ambitions, BP takes the helm of Beacon Wind projects. The deal, set to close in Q2 or Q3 2024, reshapes both companies' strategies without impacting Equinor's adjusted earnings.

News

A Look Into Consumer Cyclical Sector Value Stocks

By Benzinga Insights

August 15, 10:43 AM

What are Value Stocks? A value stock traditionally has a lower price when compared to stock prices of…

CHS

Stephens & Co. Reiterates Overweight on Stoneridge, Maintains $27 Price Target

Related Posts

Telsey Advisory Group Maintains Outperform on Deckers Outdoor, Raises Price Target to $475

What’s Going On With 4D Molecular Therapeutics Stock Today

Wind Of Change: Energy Giants Equinor & BP Give Offshore Wind Power Project Deal A Second Chance

A Look Into Consumer Cyclical Sector Value Stocks